Jim O'Neill thinks we need $2B to fund new drugs By: CNBC.com News May 14, 2015 at 04:34 AM EDT As the list of drug-resistant bacteria grows, more research into new antibiotics is needed, according to ex-Goldman Sachs economist Jim O'Neill. Read More >> Related Stocks: Goldman Sachs Group